Back to HSBC HOLDINGS PLC HSBC HOLDINGS PLC

OVIDOVID
2 quarters

Position history for HSBC HOLDINGS PLCHSBC HOLDINGS PLC's holdings in OVID THERAPEUTICS INC

No. HSBC Holdings exited its OVID (Ovid Therapeutics) position in Q3 2025. Its Q2 2025 13F listed 19,220 shares worth $6,010. HSBC Holdings first reported OVID in Q2 2025 and held it in 1 quarterly 13F filing.

Final Value

$0

Final Shares

0

Total Value Change

-$6,010

Total Shares Change

-19,220

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
Exited
0
-100.0%
$00.0%$1.30
0
2025-Q2
New
19,220
-
$6,0100.0%$0.33
24

Other major holders of OVID: Jupiter Topco LLC, BlackRock, Inc., RA CAPITAL MANAGEMENT, L.P., Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used